Remote assessments are here to stay. The FDA's increased reliance on digital audits—for both regulatory enforcement and drug application reviews—has fundamentally changed how validation teams need to prepare for scrutiny. But are your systems, documentation, and processes truly ready in this new environment?
Join us in this webinar to explore what makes a validation program audit-ready for remote assessment. We'll cover the documentation practices that build inspector confidence, the digital validation capabilities that streamline review processes, and the key differences between traditional site visits and remote evaluations. Learn how to position your validation activities for success whether the FDA shows up in person or logs in from miles away.
Hear practical insights and proven strategies from validation experts who've navigated both assessment types. This webinar is for validation, quality, or IT professionals responsible for maintaining inspection readiness and anyone who wants to ensure their validation program stands up to modern regulatory scrutiny.
Sponsored by ![]()